Genetics

OpGen (NASDAQ:OPGN) announced today that it will implement a 1-for-25 reverse stock split of its common stock. The Company filed an amendment to its Certificate of Incorporation to effect the reverse stock split on January 17, 2018. As quoted in the press release: The reverse stock split is intended to increase the market price per …

OpGen (NASDAQ:OPGN) announced today that it will implement a 1-for-25 reverse stock split of its common stock. The Company filed an amendment to its Certificate of Incorporation to effect the reverse stock split on January 17, 2018.
As quoted in the press release:

The reverse stock split is intended to increase the market price per share of the Company’s common stock to qualify it for continued listing on The Nasdaq Capital Market.  The Company had previously announced that the Listing Qualifications Staff of the Nasdaq Capital Market had determined to delist the Company’s securities from Nasdaq, effective January 2, 2018, unless the Company timely requested a hearing before the Nasdaq Hearings Panel (the “Panel”).

Click here to read the full press release.

MARKETS

Markets
TSX19089.00-133.74
TSXV626.34-18.57
DOW31040.64+93.65
S&P 5003819.16-2.39
NASD11166.87-14.67
ASX6763.60+57.60

COMMODITIES

Commodities
Gold1819.01+0.44
Silver20.78-0.04
Copper3.77-0.01
Palladium1973.50+104.50
Platinum918.00+8.00
Oil109.41-2.35
Heating Oil3.94-0.17
Natural Gas6.47-0.10

DOWNLOAD FREE REPORTS

×